<?xml version="1.0" encoding="UTF-8"?>
<ref id="B93-pharmaceuticals-12-00060">
 <label>93.</label>
 <element-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Lim</surname>
    <given-names>S.-Y.</given-names>
   </name>
   <name>
    <surname>Osuna</surname>
    <given-names>C.</given-names>
   </name>
   <name>
    <surname>Taylor</surname>
    <given-names>R.</given-names>
   </name>
   <name>
    <surname>Mathis</surname>
    <given-names>A.</given-names>
   </name>
   <name>
    <surname>Kamath</surname>
    <given-names>V.</given-names>
   </name>
   <name>
    <surname>Berger</surname>
    <given-names>E.</given-names>
   </name>
   <name>
    <surname>Babu</surname>
    <given-names>Y.</given-names>
   </name>
   <name>
    <surname>Sheridan</surname>
    <given-names>W.</given-names>
   </name>
   <name>
    <surname>Whitney</surname>
    <given-names>J.B.</given-names>
   </name>
  </person-group>
  <article-title>BCX4430, a Broad-Spectrum Adenosine Analog Direct-Acting Antiviral Drug, Abrogates Viremia in Rhesus Macaques Challenged with Zika Virus</article-title>
  <source>Open Forum Infectious Diseases</source>
  <year>2016</year>
  <pub-id pub-id-type="doi">10.1093/ofid/ofw195.05</pub-id>
 </element-citation>
</ref>
